MolNFT v1 · #135711 · protein
Structure of human niemann-pick C1 protein
5U74: “Structure of human niemann-pick C1 protein”. X-ray diffraction, 2 ligands (NAG, MAN), 9 pockets (best druggability 0.88). MolNFT v1 #135711 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 5U74
- Type
- protein
- Length
- 900 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Niemann-pick C1 protein
- UniProt
- O15118
- Ligands
- NAG, MAN
- Pockets
- 9 · best druggability 0.88
Structure
x-ray diffraction · 1 distinct chain · 55% helix, 7% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Niemann-pick C1 protein | protein | 900 | 55% helix, 7% strand | O15118 |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 14 copies · chains A
- MAN · alpha-D-mannopyranose · sugar · 2 copies · chains A
- MES · 2-(N-morpholino)-ethanesulfonic acid · additive · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
9 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 1191 | 0.88 | 0.89 | 101 | MES |
| 2 | 190 | 0.52 | 0.78 | 21 | empty |
| 3 | 107 | 0.50 | 0.81 | 19 | empty |
| 4 | 68 | 0.43 | 0.81 | 20 | empty |
| 5 | 87 | 0.35 | 0.74 | 17 | empty |
Modifications
Observed in the structure: 12 glycan, 6 disulfide (N-glycosylation, disulfide, glycosylation).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt O15118
- Elsewhere: RCSB PDB 5U74 · PDBe 5U74 · UniProt O15118
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.